ALEXA CHANDLER: Open Payments
NPI 1346876877 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 33 payments from 8 companies in 2025. Trend: 2023 $17 · 2024 $390 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $156 |
| E.R. Squibb & Sons, L.L.C. | 6 | $127 |
| Alkermes, Inc. | 6 | $122 |
| Janssen Pharmaceuticals, Inc | 4 | $104 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Lundbeck LLC | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: INGREZZA, COBENFY, ARISTADA, INVEGA SUSTENNA, HETLIOZ, ABILIFY MAINTENA, CAPLYTA, FANAPT.
Industry payments across VA — which companies pay providers there.
